Evidence map›Paper›PMID 35743229›Full record

SynthesisInternational journal of molecular sciences2022

Laminin as a Biomarker of Blood-Brain Barrier Disruption under Neuroinflammation: A Systematic Review.

Juan F Zapata-Acevedo, Valentina García-Pérez, Ricardo Cabezas-Pérez, Monica Losada-Barragán, Karina Vargas-Sánchez, Rodrigo E González-Reyes

Open access · goldAbstract readSystematic Review
In one paragraph

Synthesis in International journal of molecular sciences, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Laminins and the blood-brain barrier.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Juan F Zapata-AcevedoGrupo de Investigación en Neurociencias (NeURos), Centro de Neurociencias Neurovitae-UR, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111711, Colombia.
Valentina García-PérezGrupo de Neurociencia traslacional, Facultad de Medicina, Universidad de los Andes, Bogotá 111711, Colombia.
Ricardo Cabezas-PérezGrupo de Investigación en ciencias Biomédicas GRINCIBIO, Facultad de Medicina, Universidad Antonio Nariño, Sede Bogotá D.C., Bogotá 110231, Colombia.
Monica Losada-BarragánBiología Celular y Funcional e Ingeniería de Moléculas, Departamento de Biología, Universidad Antonio Nariño, Sede Bogotá D.C., Bogotá 110231, Colombia.
Karina Vargas-SánchezGrupo de Neurociencia traslacional, Facultad de Medicina, Universidad de los Andes, Bogotá 111711, Colombia.ORCID 0000-0002-5767-1839
Rodrigo E González-ReyesGrupo de Investigación en Neurociencias (NeURos), Centro de Neurociencias Neurovitae-UR, Instituto de Medicina Traslacional (IMT), Escuela de Medicina y Ciencias de la Salud, Universidad del Rosario, Bogotá 111711, Colombia.ORCID 0000-0002-7865-0527
Universidad Antonio Nariño · COUniversidad de Los Andes · COUniversidad del Rosario · CO

Funding

Ministerio de Ciencia Tecnología e Innovación (Minciencias) Colombia Convocatoria 528 Doctorados NacionalesMinisterio de Ciencia Tecnología e Innovación (Minciencias) Colombia CT-672-2018 (123377757091)Universidad de Los Andes FAPA KARINA VARGAS - [ P20.263622.005/01]
6 · The paper itself

Abstract

Laminin, a non-collagenous glycoprotein present in the brain extracellular matrix, helps to maintain blood-brain barrier (BBB) integrity and regulation. Neuroinflammation can compromise laminin structure and function, increasing BBB permeability. The aim of this paper is to determine if neuroinflammation-induced laminin functional changes may serve as a potential biomarker of alterations in the BBB. The 38 publications included evaluated neuroinflammation, BBB disruption, and laminin, and were assessed for quality and risk of bias (protocol registered in PROSPERO; CRD42020212547). We found that laminin may be a good indicator of BBB overall structural integrity, although changes in expression are dependent on the pathologic or experimental model used. In ischemic stroke, permanent vascular damage correlates with increased laminin expression (β and γ subunits), while transient damage correlates with reduced laminin expression (α subunits). Laminin was reduced in traumatic brain injury and cerebral hemorrhage studies but increased in multiple sclerosis and status epilepticus studies. Despite these observations, there is limited knowledge about the role played by different subunits or isoforms (such as 411 or 511) of laminin in maintaining structural architecture of the BBB under neuroinflammation. Further studies may clarify this aspect and the possibility of using laminin as a biomarker in different pathologies, which have alterations in BBB function in common.

Indexed as

Blood-Brain BarrierLamininBiomarkersBrainHumansNeuroinflammatory DiseasesBiomarkersLamininanimal modelsblood–brain barrierextracellular matrixlamininneuroinflammationneurovascular unit

Identifiers

PMID35743229
PMCPMC9224176
OpenAlexW4283023563

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.